CYP1A2 is a cytochrome P450 enzyme primarily involved in metabolizing caffeine and certain drugs. There is no robust scientific evidence that it directly helps with allergies. Allergic reactions are driven by IgE, histamine, and inflammatory mediators—pathways where CYP1A2 plays no established role. Some indirect links have been proposed, such as metabolism of arachidonic acid or activation of environmental toxins that may modulate immune responses, but these remain speculative and lack clinical validation. Genetic variants in CYP1A2 (e.g., rs762551) do not predict allergy risk or severity. For allergy assessment, validated tests like specific IgE, skin prick tests, or oral challenges are recommended. The evidence for CYP1A2 involvement in allergy is best described as mechanistic/unclear. Consumers should be cautious of claims that overstate the relevance of this gene for allergic conditions.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d8de8519af47244aa7a60e89